Skip to Content

Third Annual Da Silva Center for Ebstein's Anomaly Symposium

February 11, 2023

Third Annual Da Silva Center for Ebstein's Anomaly Symposium

Saturday, Feb. 11, 2023 from 9 a.m. to 1 p.m.

Hosted by

Victor Morell, MD
Chief, Pediatric Cardiothoracic Surgery
Co-Director, Heart Institute

Who Should Attend

This symposium is designed for pediatric cardiologists, pediatric and adult cardiac surgeons, thoracic surgeons, APPs, and other health care professionals who have an interest in pediatric and adult congenital heart disease. 

About Ebstein’s Anomaly

Ebstein’s anomaly is a rare, congenital heart defect caused by an abnormality in the tricuspid valve and right ventricle. The tricuspid valve is displaced into the right ventricle and presents variable degrees of insufficiency, often causing the valve to leak blood into the right atrium from the wrong direction. The clinical presentation of Ebstein’s anomaly is variable, as well as the timing for surgical intervention. Many patients still postpone the surgical repair of Ebstein’s anomaly due to the fear of having a tricuspid valve replaced by a prosthesis instead of repaired.

In 1993, José Pedro da Silva, MD, created the Cone technique as an alternative to tricuspid valve replacement. This procedure uses the patient’s own tissue to reconstruct the tricuspid valve into a cone shape and will grow with the patient, reducing the need for additional surgical intervention. Since then, the Cone technique has become the worldwide standard of surgical treatment for patients with Ebstein’s anomaly. 

The Da Silva Center for Ebstein’s Anomaly

Founded in 2016, the Da Silva Center for Ebstein’s Anomaly has become a world-renowned facility for treatment. Led by surgical director, Dr. da Silva, alongside Luciana da Fonseca da Silva, MD, the multidisciplinary team of specialists cares for patients of all ages with Ebstein’s anomaly. 

Dr. da Silva and Dr. da Fonseca da Silva have performed more than 260 Cone procedures to repair a range of anatomical presentations of this congenital heart defect. Their excellent surgical outcomes have helped UPMC Children’s earn the #3 ranking in Cardiology & Heart Surgery by U.S. News & World Report.